(Q36955129)

English

Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity

scientific article published on 05 August 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Sacha J Howell

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Elizabeth Anderson

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Tom Hunter

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Gillian Farnie

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Robert B Clarke

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

5 August 2008

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Breast Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

10

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

R68

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

https://scigraph.springernature.com/pub.10.1186/bcr2129

0 references

Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575541

29 September 2017

Focal adhesion kinase and protein kinase B cooperate to suppress doxorubicin-induced apoptosis of breast tumor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575541

29 September 2017

Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575541

29 September 2017

Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575541

29 September 2017

Prolactin inhibits apoptosis of ovarian carcinoma cells induced by serum starvation or cisplatin treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575541

29 September 2017

Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575541

29 September 2017

Prolactin acts as a potent survival factor for human breast cancer cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575541

29 September 2017

The survival effect of prolactin on PC3 prostate cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575541

29 September 2017

Prolactin expression and secretion by human breast glandular and adipose tissue explants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575541

29 September 2017

Prolactin influences proliferation and apoptosis of a human IgE secreting myeloma cell line, U266.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575541

29 September 2017

Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575541

29 September 2017

A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575541

29 September 2017

Evidence for a second receptor binding site on human prolactin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575541

29 September 2017

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575541

29 September 2017

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575541

29 September 2017

Inhibition of mammary tumorigenesis in carcinogen-treated Lewis rats by suppression of prolactin secretion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575541

29 September 2017

Basal prolactin blood levels in three strains of rat with differing incidence of 7,12-dimethylbenz(a)anthracene induced mammary tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575541

27 June 2018

Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575541

27 June 2018

Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways

1 reference

https://api.crossref.org/works/10.1186%2FBCR2129

21 January 2018

Human prolactin and its antagonist, hPRL-G129R, regulate bax and bcl-2 gene expression in human breast cancer cells and transgenic mice.

1 reference

https://api.crossref.org/works/10.1186%2FBCR2129

21 January 2018

Plasma prolactin concentrations and risk of postmenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1186%2FBCR2129

21 January 2018

A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.

1 reference

https://api.crossref.org/works/10.1186%2FBCR2129

21 January 2018

Development of pure prolactin receptor antagonists.

1 reference

https://api.crossref.org/works/10.1186%2FBCR2129

21 January 2018

Signal transduction pathways regulated by prolactin and Src result in different conformations of activated Stat5b

1 reference

https://api.crossref.org/works/10.1186%2FBCR2129

21 January 2018

Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth

1 reference

https://api.crossref.org/works/10.1186%2FBCR2129

21 January 2018

The role of human prolactin and its antagonist, G129R, in mammary gland development and DMBA-initiated tumorigenesis in transgenic mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575541

4 September 2018

Antiprolactinemic approach in the treatment of metastatic breast cancer: a phase II study of polyneuroendocrine therapy with LHRH-analogue, tamoxifen and the long-acting antiprolactinemic drug cabergoline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575541

4 September 2018

Expression of prolactin and its receptor in human breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18681966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland

1 reference

https://pubmed.ncbi.nlm.nih.gov/18681966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways

1 reference

https://pubmed.ncbi.nlm.nih.gov/18681966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/18681966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A possible prolactin-related adverse effect of certain antineoplastic anthracyclines

1 reference

https://pubmed.ncbi.nlm.nih.gov/18681966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18681966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PRL modulates cell cycle regulators in mammary tumor epithelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18681966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Promotion by prolactin of the growth of human breast neoplasms cultured in vitro in the soft agar clonogenic assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/18681966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolactin as a Chemoattractant for Human Breast Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18681966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolactin synthesis and secretion by human breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18681966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A

1 reference

https://pubmed.ncbi.nlm.nih.gov/18681966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/BCR2129

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Dimensions Publication ID

0 references

release_hne5vfqbdzazvlszb4bihahmdi

1 reference

https://api.fatcat.wiki/v0/release/hne5vfqbdzazvlszb4bihahmdi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36955129&oldid=1843645130"